Shanghai TTM-Bio Technology Co., Ltd
Shanghai TTM-Bio Technology Co., Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101 | Osteoporotic Fractures, bone fracture, injury | Active, not recruiting | Phase 1 | 2026-09-02 | NCT07178327 |